Linscomb & Williams Raised Apache (APA) Stake; ARGOS THERAPEUTICS (ARGS)’s Sentiment Is 0.54

October 27, 2017 - By Adrian Mccoy

Argos Therapeutics, Inc. is an immuno-oncology company. The company has market cap of $8.72 million. The Firm is focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. It currently has negative earnings. The Company’s Arcelis technology platform utilizes biological components from a patient’s own cancer cells or virus to generate individualized immunotherapies.

Linscomb & Williams Inc increased Apache Corp (APA) stake by 1319.46% reported in 2017Q2 SEC filing. Linscomb & Williams Inc acquired 60,352 shares as Apache Corp (APA)’s stock declined 7.72%. The Linscomb & Williams Inc holds 64,926 shares with $3.11 million value, up from 4,574 last quarter. Apache Corp now has $15.52 billion valuation. The stock declined 1.08% or $0.44 reaching $40.3 on the news. About 3.60M shares traded. Apache Corporation (NYSE:APA) has declined 10.21% since October 27, 2016 and is downtrending. It has underperformed by 26.91% the S&P500.

Among 26 analysts covering Apache Corporation (NYSE:APA), 5 have Buy rating, 5 Sell and 16 Hold. Therefore 19% are positive. Apache Corporation had 83 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, August 15 by Citigroup. Howard Weil upgraded the stock to “Outperform” rating in Monday, May 16 report. The stock has “Hold” rating by Argus Research on Tuesday, December 15. On Thursday, October 19 the stock rating was maintained by Cowen & Co with “Hold”. The rating was maintained by Bernstein on Thursday, March 10 with “Outperform”. Cowen & Co maintained Apache Corporation (NYSE:APA) rating on Friday, September 15. Cowen & Co has “Hold” rating and $50.0 target. The company was maintained on Friday, July 21 by Citigroup. UBS maintained the shares of APA in report on Friday, August 5 with “Neutral” rating. The stock of Apache Corporation (NYSE:APA) has “Underweight” rating given on Thursday, September 14 by JP Morgan. The rating was downgraded by Seaport Global to “Neutral” on Wednesday, June 21.

Investors sentiment decreased to 0.74 in 2017 Q2. Its down 0.26, from 1 in 2017Q1. It is negative, as 88 investors sold APA shares while 243 reduced holdings. 50 funds opened positions while 196 raised stakes. 342.91 million shares or 0.58% more from 340.94 million shares in 2017Q1 were reported. California-based Dowling Yahnke Ltd Liability Corp has invested 0.03% in Apache Corporation (NYSE:APA). Amica Mutual Ins Co has invested 0.1% in Apache Corporation (NYSE:APA). Jfs Wealth Advisors Ltd Liability Com holds 0% of its portfolio in Apache Corporation (NYSE:APA) for 313 shares. Highland Capital Mgmt Ltd Liability Com holds 0.22% or 56,278 shares. The Texas-based Tctc Ltd Llc has invested 0.07% in Apache Corporation (NYSE:APA). Guardian Life Insurance Of America has invested 0.01% in Apache Corporation (NYSE:APA). Davidson Inv Advsrs invested 0.03% in Apache Corporation (NYSE:APA). Dupont Cap Management reported 4,176 shares or 0% of all its holdings. Reilly Fin Advisors Ltd Limited Liability Company holds 0.01% or 874 shares. Scotia Cap has invested 0.01% in Apache Corporation (NYSE:APA). Hawkins Capital LP reported 1.28% stake. Nippon Life Insurance holds 19,788 shares. 431,330 were reported by Kornitzer Mngmt Ks. Murphy Mgmt accumulated 8,386 shares or 0.06% of the stock. Ardevora Asset Mgmt Ltd Liability Partnership holds 0.76% or 500,500 shares.

Linscomb & Williams Inc decreased Ishares Tr Select Divid Etf (DVY) stake by 9,501 shares to 192,912 valued at $17.79M in 2017Q2. It also reduced Wisdomtree Tr Us Midcap Divid (DON) stake by 3,578 shares and now owns 697,185 shares. Wisdomtree Tr Us High Dividend (DHS) was reduced too.

Since May 15, 2017, it had 1 insider purchase, and 0 sales for $513,800 activity. On Monday, May 15 the insider JOYCE RENE R bought $513,800.

Element Capital Management Llc holds 0.01% of its portfolio in Argos Therapeutics Inc for 82,808 shares. Bank Of America Corp De owns 6,306 shares or 0% of their US portfolio. Moreover, Bank Of New York Mellon Corp has 0% invested in the company for 25,423 shares. The United Kingdom-based Barclays Plc has invested 0% in the stock. Blackrock Inc., a New York-based fund reported 6,256 shares.

The stock decreased 1.86% or $0.003 during the last trading session, reaching $0.159. About 3.12M shares traded. Argos Therapeutics Inc (ARGS) has declined 92.57% since October 27, 2016 and is downtrending. It has underperformed by 109.27% the S&P500.